Literature DB >> 8152530

The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats.

E Przegaliński1, B Budziszewska, J Siwanowicz, L Jaworska.   

Abstract

The effect of nifedipine, a calcium channel antagonist, on changes in the density of glucocorticoid (GR) and/or mineralocorticoid receptors (MR), induced by long-term treatment with antidepressant drugs (imipramine and amitriptyline) or electroconvulsive shock (ECS) was investigated in the rat hippocampus. Long-term treatment with imipramine or amitriptyline significantly increased the density of GR, while chronic ECS significantly elevated the density of both GR and MR. Nifedipine administered repeatedly had no effect on the basal GR and MR levels, however when the rats were pretreated with nifedipine, the antidepressant drugs and ECS were unable to increase the density of GR, or GR and MR, respectively. These results indicate that, unlike in other models, nifedipine blocks the effects of antidepressant drugs and ECS on GR and/or MR. They also show, that antidepressant drugs and ECS differ in their effect on the density of GR and MR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8152530     DOI: 10.1016/0028-3908(93)90036-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  2 in total

1.  Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters.

Authors:  C M Pariante; A Makoff; S Lovestone; S Feroli; A Heyden; A H Miller; R W Kerwin
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Total flavonoids extracted from xiaobuxin-tang on the hyperactivity of hypothalamic-pituitary-adrenal axis in chronically stressed rats.

Authors:  Lei An; You-Zhi Zhang; Xin-Min Liu; Neng-Jiang Yu; Hong-Xia Chen; Nan Zhao; Li Yuan; Yun-Feng Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-05       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.